Evidence map›Paper›PMID 25835957›Full record

ArticleThe Journal of investigative dermatology2015

Self-Antigen Presentation by Keratinocytes in the Inflamed Adult Skin Modulates T-Cell Auto-Reactivity.

Michael Meister, Amel Tounsi, Evelyn Gaffal, Tobias Bald, Maria Papatriantafyllou, Julia Ludwig, Georg Pougialis, Felix Bestvater, Luisa Klotz, Gerhard Moldenhauer and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Keratinocytes: A key player in skin immunity and their emerging roles in secondary lymphedema.JID innovations : skin science from molecules to population health · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Cellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review.Clinical, cosmetic and investigational dermatology · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Michael MeisterDepartment of Molecular Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Amel TounsiDepartment of Molecular Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Evelyn GaffalDepartment of Dermatology and Allergy, Laboratory of Experimental Dermatology, University of Bonn, Bonn, Germany.
Tobias BaldDepartment of Dermatology and Allergy, Laboratory of Experimental Dermatology, University of Bonn, Bonn, Germany.
Maria PapatriantafyllouDepartment of Molecular Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Julia LudwigDepartment of Molecular Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Georg PougialisDepartment of Molecular Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Felix BestvaterCore Facility Light Microscopy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Luisa KlotzDepartment of Neurology, Clinic for Neurology, University Hospital Münster, Münster, Germany.
Gerhard MoldenhauerDepartment of Molecular Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Thomas TütingDepartment of Dermatology and Allergy, Laboratory of Experimental Dermatology, University of Bonn, Bonn, Germany.
Günter J HämmerlingDepartment of Molecular Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Bernd ArnoldDepartment of Molecular Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: b.arnold@dkfz.de.
Thilo OelertDepartment of Molecular Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Heidelberg University · DEUniversity of Bonn · DEGerman Cancer Research Center · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keratinocytes have a pivotal role in the regulation of immune responses, but the impact of antigen presentation by these cells is still poorly understood, particularly in a situation where the antigen will be presented only in adult life. Here, we generated a transgenic mouse model in which keratinocytes exclusively present a myelin basic protein (MBP) peptide covalently linked to the major histocompatibility complex class II β-chain, solely under inflammatory conditions. In these mice, inflammation caused by epicutaneous contact sensitizer treatment resulted in keratinocyte-mediated expansion of MBP-specific CD4(+) T cells in the skin. Moreover, repeated contact sensitizer application preceding a systemic MBP immunization reduced the reactivity of the respective CD4(+) T cells and lowered the symptoms of the resulting experimental autoimmune encephalomyelitis. This downregulation was CD4(+) T-cell-mediated and dependent on the presence of the immune modulator Dickkopf-3. Thus, presentation of a neo self-antigen by keratinocytes in the inflamed, adult skin can modulate CD4(+) T-cell auto-aggression at a distal organ.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAutoantigensCD4-Positive T-LymphocytesCyclopropanesDermatitisDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalGenes, MHC Class IIIntercellular Signaling Peptides and ProteinsKeratinocytesMiceMice, KnockoutMice, TransgenicMyelin Basic ProteinOxazoles4-ethoxymethylene-2-phenyl-2-oxazoline-5-oneAdaptor Proteins, Signal TransducingAutoantigensCyclopropanesdiphenylcyclopropenoneDkk3 protein, mouseIntercellular Signaling Peptides and ProteinsMyelin Basic ProteinOxazoles

Identifiers

PMID25835957
OpenAlexW2132259302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.